Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan

  • Takuya Hara
    Kawasaki Disease Center, Fukuoka Children’s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan
  • Kenji Furuno
    Kawasaki Disease Center, Fukuoka Children’s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan
  • Kenichiro Yamamura
    Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
  • Junji Kishimoto
    Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
  • Yumi Mizuno
    Kawasaki Disease Center, Fukuoka Children’s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan
  • Kenji Murata
    Kawasaki Disease Center, Fukuoka Children’s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan
  • Sagano Onoyama
    Division of Pediatrics, Japanese Red Cross Fukuoka Hospital, Ookusu, Minami-Ku, Fukuoka, Japan
  • Ken Hatae
    Division of Pediatrics, Japanese Red Cross Fukuoka Hospital, Ookusu, Minami-Ku, Fukuoka, Japan
  • Megumi Takemoto
    Division of Pediatrics, Hamanomachi Hospital, Nagahama, Chuo-ku, Fukuoka, Japan
  • Yoshito Ishizaki
    Division of Pediatrics, National Hospital Organization Fukuokahigashi Medical Center, Chidori, Koga, Fukuoka, Japan
  • Shunsuke Kanno
    Division of Pediatrics, National Hospital Organization Kyushu Medical Center, Jigyohama, Chuo-ku, Fukuoka, Japan
  • Kazuo Sato
    Division of Pediatrics, National Hospital Organization Kyushu Medical Center, Jigyohama, Chuo-ku, Fukuoka, Japan
  • Yoshitomo Motomura
    Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
  • Yasunari Sakai
    Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
  • Shouichi Ohga
    Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan
  • Mayumi Yashiro
    Department of Public Health, Jichi Medical University, Yakushiji, Shimotsuke, Tochigi, Japan
  • Yoshikazu Nakamura
    Department of Public Health, Jichi Medical University, Yakushiji, Shimotsuke, Tochigi, Japan
  • Toshiro Hara
    Kawasaki Disease Center, Fukuoka Children’s Hospital, Kashiiteriha, Higashi-ku, Fukuoka, Japan

説明

The development of Kawasaki disease (KD) has been suggested to be associated with droplet- or contact-transmitted infection; however, its triggers and transmission modes remain to be determined. Under an epidemic of SARS-CoV-2, the COVID-19 state of emergency in Japan served as a nationwide social experiment to investigate the impact of quarantine or isolation on the incidence of KD.To assess the role of droplet or contact transmission in the etiopathogenesis of KD.This multicenter, longitudinal, cross-sectional study was conducted from 2015 to 2020 at Fukuoka Children's Hospital and 5 adjacent general hospitals. The number of admissions for KD and infectious diseases were analyzed. Participants were pediatric patients admitted to the participating hospitals for KD or infectious diseases.Quarantine and isolation owing to the COVID-19 state of emergency.The primary end points were the ratios of patients with KD to patients with respiratory tract or gastrointestinal infections admitted from April to May in 2015 to 2019 and 2020. A Poisson regression model was used to analyze them.The study participants included 1649 patients with KD (median [interquartile range] age, 25 [13-43] months; 901 boys [54.6%]) and 15 586 patients with infectious disease (data on age and sex were not available for these patients). The number of admissions for KD showed no significant change between April and May in 2015 to 2019 vs the same months in 2020 (mean [SD], 24.8 [5.6] vs 18.0 [4.0] admissions per month; 27.4% decrease; adjusted incidence rate ratio [aIRR], 0.73; 95% CI, 0.48-1.10; P = .12). However, the number of admissions for droplet-transmitted or contact-transmitted respiratory tract infections (mean [SD], 157.6 [14.4] vs 39.0 [15.0] admissions per month; 75.3% decrease; aIRR, 0.25; 95% CI, 0.17-0.35; P  .001) and gastrointestinal infections (mean [SD], 43.8 [12.9] vs 6.0 [2.0] admissions per month; 86.3% decrease; aIRR, 0.14; 95% CI, 0.04-0.43; P  .001) showed significant decreases between April and May in 2015 to 2019 vs the same months in 2020 (total, 12 254 infections). Thus, the ratio of KD to droplet- or contact-transmitted respiratory tract and gastrointestinal infections incidence in April and May 2020 was significantly increased (ratio, 0.40 vs 0.12; χ21 = 22.76; P  .001).In this study, the significantly increased incidence of KD compared with respiratory tract and gastrointestinal infections during the COVID-19 state of emergency suggests that contact or droplet transmission is not a major route for KD development and that KD may be associated with airborne infections in most cases.

収録刊行物

  • JAMA Network Open

    JAMA Network Open 4 (4), e214475-, 2021-04-06

    American Medical Association (AMA)

被引用文献 (2)*注記

もっと見る

参考文献 (54)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ